| __timestamp | Incyte Corporation | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 347523000 | 7459000 |
| Thursday, January 1, 2015 | 479514000 | 11831000 |
| Friday, January 1, 2016 | 581861000 | 25705000 |
| Sunday, January 1, 2017 | 1326361000 | 46181000 |
| Monday, January 1, 2018 | 1197957000 | 59497000 |
| Tuesday, January 1, 2019 | 1154111000 | 65003000 |
| Wednesday, January 1, 2020 | 2215942000 | 74506000 |
| Friday, January 1, 2021 | 1458179000 | 126006000 |
| Saturday, January 1, 2022 | 1585936000 | 126215000 |
| Sunday, January 1, 2023 | 1627594000 | 120161000 |
| Monday, January 1, 2024 | 2606848000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Protagonist Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Incyte Corporation, a leader in the field, has consistently increased its R&D spending, peaking in 2020 with a staggering 2.2 billion dollars. This represents a nearly 500% increase from 2014, showcasing their aggressive pursuit of new therapies. In contrast, Protagonist Therapeutics, Inc., while smaller in scale, has also shown a steady increase in R&D investment, growing by over 1,500% from 2014 to 2023.
These trends highlight the dynamic nature of the biotech industry, where strategic R&D investments can lead to groundbreaking advancements and significant market shifts.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
R&D Insights: How GSK plc and Protagonist Therapeutics, Inc. Allocate Funds
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending